Neurocrine Biosciences (NBIX) OCF US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
OCF, bln rub | ? | 152.1 | 228.5 | 256.5 | 339.4 | 389.9 | 476.4 | ||
Changes by years, y/y, % | +50% | +50% | +12% | +32% | +15% | +30.9% |
Neurocrine Biosciences. OCF, bln rub
Neurocrine Biosciences. OCF, changes, %
Neurocrine Biosciences. OCF, sum by quarters, bln rub
Neurocrine Biosciences (NBIX) OCF US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
OCF, bln rub | ? | 212.0 | 123.5 | 130.3 | 64.6 | 158.0 | 476.4 | |
Changes by years, y/y, % | +115% | -14% | -204% | -64% | -25% | |||
Changes by quarters, q/q, % | +18% | -42% | +6% | -50% | +145% |